Molecular and pharmacodynamic interactions between caffeine and dopaminergic system
Many drugs targeting dopaminergic system were developed for treating schizophrenia (antagonists of D2 dopaminergic receptors, e.g. antipsychotics) or Parkinson’ disease (agonists of dopaminergic receptors, e.g. L-DOPA)....